Log In
Print
BCIQ
Print
Print this Print this
 

raxibacumab (formerly ABthrax)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionHuman mAb against Bacillus anthracis protective antigen
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentApproved
Standard IndicationAnthrax
Indication DetailsTreat anthrax infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today